Fig. 1: CV3-25 neutralizes SARS-CoV-2 variants and a SARS-like Bat virus.
From: Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
The S2-binding CV3-25 (a), RBD-binding CV30 (b) and anti-EBV mAb AMMO1 (c) were evaluated for their ability to neutralize the indicated SARS-CoV-2 variants of concern and the SARS-like bat virus WIV1 in a pseudovirus assay. Each dot represents a technical replicate from one or two independent experiments. Curve fits are shown as solid lines.
